Prevention of vasoplegia with CytoSorb in heart failure patients undergoing cardiac surgery (CytoSorb-HF trial): protocol for a randomised controlled trial

Prevention of vasoplegia with CytoSorb in heart failure patients undergoing cardiac surgery (CytoSorb-HF trial): protocol for a randomised controlled trial

Introduction Vasoplegia is a common complication after cardiac surgery and is associated with poor prognosis. It is characterised by refractory hypotension despite normal or even increased cardiac output. The pathophysiology is complex and includes the systemic inflammatory response caused by cardio...

Full description

Bibliographic Details
Main Authors: Can Ince, Jan H N Lindeman, Wilbert B van den Hout, Saskia L M A Beeres, Robert J M Klautz, Olga Papazisi, Eline F Bruggemans, Remco R Berendsen, Juan D V Hugo, M Sesmu Arbous, Bart J A Mertens, Meindert Palmen
Format: Article
Language:English
Published: BMJ Publishing Group 2022-09-01
Series:BMJ Open
Online Access:https://bmjopen.bmj.com/content/12/9/e061337.full

Internet

https://bmjopen.bmj.com/content/12/9/e061337.full

Similar Items